Leachables/Extractables/Particulates

Leachables/Extractables/Particulates Companies (2)

Leachables/Extractables/Particulates News

Leachables/Extractables/Particulates Products (6)

  • Product Nasal Drug Development

    Development of nasal drugs: Scientists from our nasal drug development team provide method development, validation, and testing services to help you optimise the performance of your aqueous, powder, and propellant-driven nasal drug products. Conducted in Good Manufacturing Compliant (GMP) laborato...
  • Product Extractables & Leachables

    There are many contaminants that could be released inside a drug during the production process or by contact with the packaging material. Neotron Pharma will be able to support you from the study of Extractables, to the toxicological evaluation up to the control of the Leachables. What distinguishes us is ...
  • Product Extractables & Leachables

    Extractables & leachables studies enable drug sponsors to quantify and identify the risks of potentially toxic leachable impurities migrating into a drug solution from container closure systems, processing equipment or packaging. Regulatory bodies such as the US Food and Drug Administration (FDA) and T...
  • Product Pharmaceutical Product Testing

    Element’s pharmaceutical laboratories provide specialist pharmaceutical testing services, including chemical and physical characterization, formulation development, microbial, stability and elemental impurity testing on a wide range of products, from raw materials to finished products.
  • Product Extractables & Leachables Testing

    Element's E&L teams use industry-leading expertise, in-depth knowledge of materials and regulatory requirements to help customers assess the potential for leachables, develop strategies to evaluate risk and provide a solid risk-based set of supporting data.
  • Product Extractables and Leachables studies

    Extractables/Leachables (E&L) profiles have as a primary purpose identifying any potential chemicals derived from the chemical interactions of a drug with the packaging components ,or the interaction within the pharmaceutical drug formulation.
    In addition, E&L is a FDA, ICH, and USP studies...

Upcoming Events

  • CPHI Japan 2024

    East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
    17 Apr 2024 – 19 Apr 2024
  • CPHI North America 2024

    Pennsylvania Convention Center, Philadelphia
    07 May 2024 - 09 May 2024
  • CPHI & PMEC China 2024

    Shanghai New International Expo Center
    19 - 21 June 2024

Pharmaceutical Industry Webinars